Receives EIR for SEZ II manufacturing facility - Zydus Lifesciences Ltd

Code BSE: 532321 NSE:

We wish to inform that the USFDA conducted an inspection at the group’s manufacturing plant located SEZ – II, Ahmedabad, from 11th to 14th August 2025. The inspection was a Pre-Approval Inspection (PAI). The USFDA has concluded this inspection as closed. The inspection concluded with NIL observations. The EIR has classified the facility as No Action Indicated.